
A blood test to diagnose Alzheimer’s disease? – 3 questions to Vincent Bouteloup
Major publicationVincent Bouteloup, a PhD student in Epidemiology in the PHARes team at the BPH, and his colleagues have analysed the predictive value of a biomarker present in the blood, phospho-tau 217 protein (p-tau217), which quantifies the presence of cerebral amyloid plaques causing the lesions characteristic of Alzheimer’s disease. At present, the quantification of these plaques […]
